D.B. Root & Company, LLC Regeneron Pharmaceuticals, Inc. Transaction History

D.B. Root & Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$299.6 - $414.82 $247,170 - $342,226	-825 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$372.08 - $439.57 $22,324 - $26,374	-60 Reduced 6.78%	825 $339,000
Q4 2018 Jan 25, 2019	SELL	$335.82 - $403.04 $142,723 - $171,292	-425 Reduced 32.44%	885 $331,000
Q3 2018 Nov 05, 2018	SELL	$351.14 - $408.51 $316,026 - $367,659	-900 Reduced 40.72%	1,310 $529,000
Q2 2018 Jul 25, 2018	BUY	$284.6 - $344.99 $34,152 - $41,398	120 Added 5.74%	2,210 $762,000
Q1 2018 May 02, 2018	BUY	$315.82 - $393.78 $660,063 - $823,000	2,090 New	2,090 $720,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of D.B. Root & Company, LLC, based on Form 13F filings with the SEC.

Stay updated on D.B. Root & Company, LLC with notifications on news.